These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22017171)

  • 21. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K; Lories RJ
    Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 24. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.
    Burns AM; Green PJ; Pasternak S
    J Cutan Pathol; 2012 Feb; 39(2):289-93. PubMed ID: 21899592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The short-term efficacy and safety treatment study of recurrent uveitis in Behcet disease with etanercept].
    Zhang MF; Zhao C; Wen X; Du H; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):145-50. PubMed ID: 20388349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
    Magliocco MA; Gottlieb AB
    J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
    Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
    Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].
    de Oliveira SK; de Almeida RG; Fonseca AR; Rodrigues MC; Sztajnbok F; Diniz C
    Acta Reumatol Port; 2007; 32(2):139-50. PubMed ID: 17572652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcoid-like granulomatous disease following etanercept treatment for RA.
    Kudrin A; Chilvers ER; Ginawi A; Hazleman BL; Griffiths MH; Thiru S; Ostor AJ
    J Rheumatol; 2007 Mar; 34(3):648-9. PubMed ID: 17343313
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 31. Do TNF-blockers reduce or induce uveitis?
    Cobo-Ibáñez T; del Carmen Ordóñez M; Muñoz-Fernández S; Madero-Prado R; Martín-Mola E
    Rheumatology (Oxford); 2008 May; 47(5):731-2. PubMed ID: 18346974
    [No Abstract]   [Full Text] [Related]  

  • 32. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].
    Pontikaki I; Gerloni V; Gattinara M; Luriati A; Salmaso A; De Marco G; Teruzzi B; Valcamonica E; Fantini F
    Reumatismo; 2006; 58(1):31-8. PubMed ID: 16639486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
    Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
    Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
    Mohan AK; Coté TR; Block JA; Manadan AM; Siegel JN; Braun MM
    Clin Infect Dis; 2004 Aug; 39(3):295-9. PubMed ID: 15306993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
    Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
    Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe hypercalcemia revealing sarcoidosis precipitated by etanercept].
    Watrin A; Royer M; Legrand E; Gagnadoux F
    Rev Mal Respir; 2014 Mar; 31(3):255-8. PubMed ID: 24680117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
    Girolomoni G; Abeni D
    Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of dystrophic epidermolysis bullosa improved with etanercept for concomitant psoriatic arthritis.
    Gubinelli E; Angelo C; Pacifico V
    Am J Clin Dermatol; 2010; 11 Suppl 1():53-4. PubMed ID: 20586512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.